Cargando…

ARDS From Syndrome to Disease—Treatment Strategies

Detalles Bibliográficos
Autor principal:	Dries, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Air Medical Journal Associates. Published by Elsevier Inc. 2019
Materias:	Critical Care Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950818/ https://www.ncbi.nlm.nih.gov/pubmed/30898284 http://dx.doi.org/10.1016/j.amj.2018.12.003

Ejemplares similares

Coronavirus Disease 2019: From Exposure to the Intensive Care Unit—Part 1
por: Dries, David J.
Publicado: (2021)

Coronavirus Disease 2019: From Intensive Care Unit to the Long Haul—Part 2
por: Dries, David J.
Publicado: (2021)

Coronavirus Disease 2019: Women and Children
por: Dries, David J.
Publicado: (2021)

The Virus II: Triage and Treatment
por: Suresh, Mithun R., et al.
Publicado: (2020)

Coronavirus Disease 2019 and Stroke
por: Dries, David J., et al.
Publicado: (2021)

Extracorporeal Membrane Oxygenation and the Virus
por: Dries, David J.
Publicado: (2020)

Vaccination
por: Dries, David J.
Publicado: (2022)

Monkeypox
por: Dries, David J.
Publicado: (2022)

Delta and the Variants
por: Suresh, Mithun R., et al.
Publicado: (2022)

Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)
por: Dancer, Rachel C A, et al.
Publicado: (2015)

COVID-19 AND A HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME IN THE ABSENCE OF ARDS
por: White, Kyle, et al.
Publicado: (2020)

Tidal changes on CT and progression of ARDS
por: Cereda, Maurizio, et al.
Publicado: (2017)

PROLONGED, PROFOUND UNTREATED HYPOXIA IN COVID-19 ARDS WITH REFUSAL OF TREATMENT
por: THOMAS, KALEB, et al.
Publicado: (2021)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

PROPOFOL-RELATED INFUSION SYNDROME IN A PATIENT WITH ARDS SECONDARY TO THE NOVEL COVID-19
por: FREEMAN, HOWARD, et al.
Publicado: (2021)

ARDS following oesophagectomy: a comparison of two trials
por: Howells, Phillip A, et al.
Publicado: (2017)

PROVIDER EXPERIENCE WITH PRONE POSITIONING FOR ARDS DURING COVID-19
por: HOCHBERG, CHAD, et al.
Publicado: (2021)

MANAGEMENT OF PNEUMOTHORAX AND PNEUMOMEDIASTINUM IN COVID-19 PATIENTS WITH ARDS
por: BAKER, COLBY M., et al.
Publicado: (2022)

EXTRA-CORPOREAL CARBON DIOXIDE REMOVAL IN COVID-19 ARDS
por: Boparai, Sukhmani, et al.
Publicado: (2020)

CHANGES IN ARDS MANAGEMENT AS A RESULT OF THE COVID-19 PANDEMIC
por: MACHURICK, MAXWELL, et al.
Publicado: (2021)

ENDOTRACHEAL INTUBATION TIMING AND OUTCOME IN ARDS DUE TO COVID-19 INFECTION
por: PEREZ GUTIERREZ, VICTOR, et al.
Publicado: (2021)

ELEVATED D-DIMER PREDICTS DETERIORATION OF ARDS IN PATIENTS WITH COVID-19
por: LOPEZ RUIZ, ARNALDO, et al.
Publicado: (2021)

PNEUMOTHORAX, PNEUMOMEDIASTINUM, AND SUBCUTANEOUS EMPHYSEMA IN COVID-19 ARDS: OUR EXPERIENCE
por: FALSINI, L., et al.
Publicado: (2022)

OLD MEDICINE FOR NEW PROBLEMS: POTENTIAL ROLE OF A NOVEL TREATMENT USING NEBULIZED HEPARIN IN COVID-19 ARDS
por: DOUEN, AARON, et al.
Publicado: (2021)

The Effect of Alcohol Consumption on the Risk of ARDS: A Systematic Review and Meta-Analysis
por: Simou, Evangelia, et al.
Publicado: (2018)

A CASE OF PRIAPISM IN A MAN ADMITTED TO THE ICU FOR COVID-19 ARDS
por: ANDERSEN, KARL, et al.
Publicado: (2021)

CIRCULATING DAMAGE-ASSOCIATED MOLECULAR PATTERNS (DAMPS) AS PROGNOSTIC MARKERS OF DISEASE SEVERITY IN PATIENTS WITH COVID-19 ARDS IN THE ICU
por: ALGHANIM, FAHID, et al.
Publicado: (2022)

COVID-19-RELATED ARDS PHENOTYPES AND PROGRESSION BETWEEN THEM: A CASE REPORT
por: Steff, Rodney, et al.
Publicado: (2020)

USE OF TISSUE PLASMINOGEN ACTIVATOR IN COVID-19 ARDS: A RETROSPECTIVE CASE SERIES
por: NEMEH, CHRISTOPHER, et al.
Publicado: (2021)

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19
por: HAFEEZ, ZEESHAN, et al.
Publicado: (2021)

DOES EXTRACORPOREAL MEMBRANE OXYGENATION SAVE LIVES IN COVID-19-ASSOCIATED SEVERE ARDS
por: VARGHESE, JOBIN, et al.
Publicado: (2021)

CORRELATION OF C-REACTIVE PROTEIN (CRP) WITH ICU COVID-19 ARDS MORTALITY IN ADULTS
por: CHANDRAN, RAVI T, et al.
Publicado: (2022)

Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study
por: Spadaro, Savino, et al.
Publicado: (2017)

IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION
por: Wadud, Nafisa, et al.
Publicado: (2020)

COMPARISON OF COVID-19 PATIENTS ADMITTED TO THE HOSPITAL WITH ARDS AND THOSE WHO PROGRESS TO IT DURING HOSPITALIZATION
por: IMRAN, MARYAM, et al.
Publicado: (2021)

OUTCOMES OF EXTRACORPOREAL MEMBRANE OXYGENATION IN ARDS DUE TO COVID-19: COMPARISON OF THE FIRST AND THE SECOND WAVE
por: REDDY, ROHIT, et al.
Publicado: (2021)

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience
por: Mahida, Rahul Y, et al.
Publicado: (2020)

AIRWAY PRESSURE RELEASE VENTILATION USE IN COVID-19 ARDS: A SINGLE CENTER OBSERVATIONAL STUDY
por: PERINKULAM SATHYANARAYANAN, SWAMINATHAN, et al.
Publicado: (2021)

IMPROVING COMPLIANCE WITH CONTINUOUS ANTERIOR CHEST COMPRESSION IN ARDS CAUSED BY COVID-19: A CASE SERIES
por: PENG, JASON L, et al.
Publicado: (2022)

PRONE POSITIONING IN COVID-19 VS NON-COVID-19 ARDS IN THE EARLY COVID-19 PANDEMIC
por: LIEBERMAN, ALLYSON E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hrhama4okv2soagvbvus2td0cj